Don't think that Valeant is over extended and can't buy Galderma. They are a Canadian based company which makes their taxes better, they have nearly unlimited borrowing ability (and a internal personal connection to the highest levels of JP Morgan Chase), it makes sense for them and they want to rule the world. I could see Allergan making a run at it too, but they don't have the financial abilities that Valeant has.
Galderma will be sold, it is inevitable. With the lack of products, a pipeline ripe with line extensions and a very overloaded staff its a no brainer. Valeant can come in and pick it up for a good price, layoff a large portion of the employees (both top and bottom) and become very profitable. That is their model and it has been very successful for them. Galderma is the low hanging fruit they've been waiting for to catapult them to the very top of the pharma industry.
Good luck to everyone and for many of you...don't let the door hit you on the ass on the way out (CP, KG, TR, MC, BJ, SS of Denver)